Virk ZM - Search Results

1

Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia.

Virk ZM, Patel AA, Leaf RK, Al-Samkari H. Virk ZM, et al. Am J Hematol. 2021 Dec 1;96(12):1611-1620. doi: 10.1002/ajh.26359. Epub 2021 Oct 7. Am J Hematol. 2021. PMID: 34553418 Free article.

2

An evaluation of avatrombopag for the treatment of thrombocytopenia.

Virk ZM, Kuter DJ, Al-Samkari H. Virk ZM, et al. Expert Opin Pharmacother. 2021 Feb;22(3):273-280. doi: 10.1080/14656566.2020.1841748. Epub 2020 Nov 11. Expert Opin Pharmacother. 2021. PMID: 33095074

3

Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement.

Virk ZM, Song AB, Badran YR, Al-Samkari H. Virk ZM, et al. J Thromb Thrombolysis. 2022 Aug;54(2):255-259. doi: 10.1007/s11239-022-02677-7. Epub 2022 Jul 13. J Thromb Thrombolysis. 2022. PMID: 35829837

4

Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia.

Virk ZM, Zhang E, Rodriguez-Lopez J, Witkin A, Wong AK, Luther J, Lin AE, Ning M, Grabowski E, Holbrook EH, Al-Samkari H. Virk ZM, et al. J Thromb Haemost. 2023 Jan;21(1):26-36. doi: 10.1016/j.jtha.2022.09.003. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36695393 Free PMC article.

5

Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review.

Zhang E, Virk ZM, Rodriguez-Lopez J, Al-Samkari H. Zhang E, et al. Among authors: virk zm. Thromb Res. 2023 Jun;226:150-155. doi: 10.1016/j.thromres.2023.04.017. Epub 2023 May 3. Thromb Res. 2023. PMID: 37163869 Free PMC article. Review.

6

Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia.

Virk ZM, Richardson TL, Al-Samkari H. Virk ZM, et al. J Thromb Thrombolysis. 2023 Aug;56(2):355-359. doi: 10.1007/s11239-023-02839-1. Epub 2023 Jun 20. J Thromb Thrombolysis. 2023. PMID: 37340288 Free PMC article.

7

Avatrombopag for adults with early versus chronic immune thrombocytopenia.

Virk ZM, Leaf RK, Kuter DJ, Goodarzi K, Connell NT, Connors JM, Al-Samkari H. Virk ZM, et al. Am J Hematol. 2024 Feb;99(2):155-162. doi: 10.1002/ajh.27080. Epub 2023 Dec 8. Am J Hematol. 2024. PMID: 38063420

8

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women.

Zhang E, Virk ZM, Rodriguez-Lopez J, Al-Samkari H. Zhang E, et al. Among authors: virk zm. Blood Adv. 2024 Jun 25;8(12):3166-3172. doi: 10.1182/bloodadvances.2023011961. Blood Adv. 2024. PMID: 38593443 Free PMC article.

9

Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.

Chua IS, Ransohoff JR, Ehrlich O, Katznelson E, Virk ZM, Demetriou CA, Petrides AK, Orav EJ, Schiff GD, Melanson SEF. Chua IS, et al. Among authors: virk zm. Pain Physician. 2021 Mar;24(2):E191-E201. Pain Physician. 2021. PMID: 33740356 Free article.

10

A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features.

Zaki MM, Virk ZM, Lopez D, Klubnick J, Ahrendsen JT, Varma H, Kyttaris V, Abeles I. Zaki MM, et al. Among authors: virk zm. Eur J Rheumatol. 2021 Jan;8(1):36-39. doi: 10.5152/eurjrheum.2020.20064. Epub 2021 Jan 1. Eur J Rheumatol. 2021. PMID: 33372889 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters